KRAKacquisition
KRAQU · NASDAQ
About KRAQU
- Employees
- 0
- Headquarters
- Menlo Park, California
- Listed
- Jan 28, 2026
- Sector
- N/A
- Industry
- N/A
KRAQU key statistics
- Market cap
- 432.97M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 188
- Volume
- 101
- Open price
- $10.12
- High today
- $10.07
- Low today
- $10.07
- 52 Week high
- $10.50
- 52 Week low
- $10.01
KRAKacquisition (KRAQU) at a glance
As of Nov 13, 2026, KRAKacquisition (KRAQU) shares are priced at $10.07, giving the company a market cap of 432.97M and a price-to-earnings ratio of 0.00.
Volume so far is 101 shares, below the average of 188 shares a day.
Over the past year KRAKacquisition has ranged from $10.01 to $10.50, and now sits 12% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+17.65%
- SHFSSHF Holdings$0.0303+34.67%
- NVDANVIDIA$162.85−2.01%
- TIPSTianrong Internet Products & Services$0.0006+50.00%
- ZBAOZhibao Technology$0.2794+32.54%
- SOXLDirexion Shares ETF Trust$58.32−10.99%
- ONFOOnfolio Holdings$0.7745+128.87%
- AITXArtificial Intelligence Technology Solutions$0.0003+0.00%
- NUNu Holdings$13.22+11.75%
- HADVHealth Advance$0.0003+0.00%
- PARAParabolic Technologies$0.107+6.26%
- RAINRain Enhancement Technologies Holdco$0.7499+58.31%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.60+0.33%
- ASPEAspen Neuroscience$12.59−7.49%
- BBTXBambusa Therapeutics$16.09−3.94%
- GBCGEORGIA BANKING$34.11−1.84%
- BHAIUBHAV Acquisition Corp II$10.01−0.06%
- SCQCUSPACCircle Acquisition$10.01−0.10%
- LYCALycia Therapeutics$31.20−4.96%
- DAVIDAVION HEALTHCARE$1.00−15.97%
- TCXBTCGX Acquisition Corp. II$10.25+0.89%
- CTYCITY THERAPEUTICS$18.10−4.64%
- IAMIambic Therapeutics$13.10−11.73%
- AMROAmaero$5.50−14.06%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.